VIKTORIA-2 Trial Evolves to Evaluate Gedatolisib in Endocrine-Sensitive and -Resistant Breast Cancer
Significant protocol amendments have been made to the ongoing phase 3 VIKTORIA-2 clinical trial (NCT06757634).The study, ...
CAR T therapy spreads beyond academic centers, but insurance, cost and policy gaps keep most eligible lymphoma patients from ...
FDA fast track status was supported by two monotherapy responses in MSI-H colorectal cancer, including one complete response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results